advertisement

---

Varma R 13

Showing records 1 to 13 | Display all abstracts from Varma R

70238 Baseline Fourier-Domain Optical Coherence Tomography Structural Risk Factors for Visual Field Progression in the Advanced Imaging for Glaucoma Study
Zhang X
American Journal of Ophthalmology 2016; 172: 94-103

---

70272 Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine
Fini ME; Schwartz SG
Progress in Retinal and Eye Research 2017; 56: 58-83

---

70238 Baseline Fourier-Domain Optical Coherence Tomography Structural Risk Factors for Visual Field Progression in the Advanced Imaging for Glaucoma Study
Dastiridou A
American Journal of Ophthalmology 2016; 172: 94-103

---

70272 Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine
Gao X
Progress in Retinal and Eye Research 2017; 56: 58-83

---

70238 Baseline Fourier-Domain Optical Coherence Tomography Structural Risk Factors for Visual Field Progression in the Advanced Imaging for Glaucoma Study
Francis BA; Tan O
American Journal of Ophthalmology 2016; 172: 94-103

---

70272 Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine
Jeong S; Patel N
Progress in Retinal and Eye Research 2017; 56: 58-83

---

70238 Baseline Fourier-Domain Optical Coherence Tomography Structural Risk Factors for Visual Field Progression in the Advanced Imaging for Glaucoma Study
Varma R; Greenfield DS
American Journal of Ophthalmology 2016; 172: 94-103

---

70272 Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine
Itakura T; Price MO
Progress in Retinal and Eye Research 2017; 56: 58-83

---

70238 Baseline Fourier-Domain Optical Coherence Tomography Structural Risk Factors for Visual Field Progression in the Advanced Imaging for Glaucoma Study
Schuman JS; Sehi M
American Journal of Ophthalmology 2016; 172: 94-103

---

70272 Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine
Price FW; Varma R
Progress in Retinal and Eye Research 2017; 56: 58-83

---

70238 Baseline Fourier-Domain Optical Coherence Tomography Structural Risk Factors for Visual Field Progression in the Advanced Imaging for Glaucoma Study
Chopra V
American Journal of Ophthalmology 2016; 172: 94-103

---

70272 Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine
Stamer WD
Progress in Retinal and Eye Research 2017; 56: 58-83

---

70238 Baseline Fourier-Domain Optical Coherence Tomography Structural Risk Factors for Visual Field Progression in the Advanced Imaging for Glaucoma Study
Huang D;
American Journal of Ophthalmology 2016; 172: 94-103

---